Anti-CTL-Associated Antigen 4: Are Regulatory T Cells a Target?

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2820
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

The Wilms' Tumor Antigen Is a Novel Target for Human CD4+ Regulatory T Cells: Implications for Immunotherapy

Cancer Research
Cancer ResearchOncology
2008English

Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-Tumor T Cell Responses

Immunity
Infectious DiseasesAllergyImmunology
2015English

Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated With Impaired T-Cell Functionality

Cancer Research
Cancer ResearchOncology
2013English

Effect of SLE Anti-T Cell Antibodies on Regulatory T Cells

Japanese Journal of Clinical Immunology
1980English

Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells

OncoTargets and Therapy
OncologyPharmacology
2019English

Human Regulatory T Cells Inhibit Polarization of T Helper Cells Toward Antigen-Presenting Cells via a TGF- -Dependent Mechanism

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Anti-Regulatory T Cell Vaccines in Immunotherapy: Focusing on FoxP3 as Target

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

Engineering HIV-Resistant, Anti-Hiv Chimeric Antigen Receptor T Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy